Acumen Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABOS and other ETFs, options, and stocks.

About ABOS

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. 

CEO
Daniel J. O'Connell
CEODaniel J. O'Connell
Employees
61
Employees61
Headquarters
Newton, Massachusetts
HeadquartersNewton, Massachusetts
Founded
1996
Founded1996
Employees
61
Employees61

ABOS Key Statistics

Market cap
170.78M
Market cap170.78M
Price-Earnings ratio
-1.23
Price-Earnings ratio-1.23
Dividend yield
Dividend yield
Average volume
342.49K
Average volume342.49K
High today
$2.44
High today$2.44
Low today
$2.35
Low today$2.35
Open price
$2.43
Open price$2.43
Volume
229.67K
Volume229.67K
52 Week high
$3.60
52 Week high$3.60
52 Week low
$0.9586
52 Week low$0.9586

Stock Snapshot

The current Acumen Pharmaceuticals(ABOS) stock price is $2.37, with a market capitalization of 170.78M. The stock trades at a price-to-earnings (P/E) ratio of -1.23.

On 2026-04-29, Acumen Pharmaceuticals(ABOS) stock traded between a low of $2.35 and a high of $2.44. Shares are currently priced at $2.37, which is +0.6% above the low and -3.1% below the high.

Acumen Pharmaceuticals(ABOS) shares are trading with a volume of 229.67K, against a daily average of 342.49K.

During the past year, Acumen Pharmaceuticals(ABOS) stock moved between $0.96 at its lowest and $3.60 at its peak.

During the past year, Acumen Pharmaceuticals(ABOS) stock moved between $0.96 at its lowest and $3.60 at its peak.

People also own

Based on the portfolios of people who own ABOS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.